Skip to content

Author

E. Spatz

We have 3 of 519 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Lipoprotein(a) and statin indications in low-risk patients based on the 2026 ACC/AHA dyslipidemia guideline

Background Though elevated lipoprotein (a) (Lp[a]) is associated with ASCVD and testing is recommended for all adults, how to use Lp(a) for decision-making in low-risk patients remains uncertain. Methods We studied low-risk adults in a large healthcare system, excluding those on statins or with statin indications in th...

K. F. Faridi, Qi-Fan Wu, E. Spatz et al. · 0 citations
Review Open access Jul 2026

All-Cause and Disease-Specific Mortality Among U.S. Adults Living With Co-Existing Cancer and Atherosclerotic Cardiovascular Disease

Among community-dwelling U.S. adults living with cancer and/or ASCVD, co-existing disease was associated with substantially higher mortality and underscore the importance of integrated cardio-oncology care.

Reed Mszar, Leah M. Ferrucci, D. Satti et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.